Definiens was founded in 1994 by Professor Gerd Binnig, the 1986 Nobel Laureate in Physics. Today, customers from all around the world use Definiens software solutions to maximize the value of their images and aid decision-making processes.
Definiens biomedical image and data analysis software ensures high returns on investment by delivering faster results and deeper insights, which lead to better decisions. Definiens software is being used to accelerate and improve research in drug discovery, development, and diagnostics. For example, radiologists and other medical experts use our software to volumetrically analyze the size of lesions. With automatic comparison and precise quantification over time, a cancer’s progression or remission can be accurately assessed.
The inspiration behind Definiens is the human mind's phenomenal ability to extract pertinent information from images. Together with his team, Gerd Binnig has developed the revolutionary Definiens Cognition Network Technology®, which emulates how the human mind understands images.
Definiens Cognition Network Technology® extracts meaningful, context-specific intelligence from any type of data, be it text, image, numerical, or table format. Our technology represents a revolutionary approach to image analysis, combining the expertise of scientists and image analysts with the speed and accuracy of advanced computing.
Just like the human mind, Definiens’ technology can segment and classify complex objects, perceiving the relationships between them as well as their contexts. It then analyzes these insights to intelligently extract the required data. This groundbreaking approach is at the heart of all of Definiens’ software solutions.
In 2000, Definiens became a commercial enterprise with venture capital from TVM (Techno Venture Management) and several angel investors. In recent years, Definiens has attracted further funding, such as from CIPIO Partners, a shareholder since 2005.
Although the potential applications of the Definiens Cognition Network Technology® encompass many types of data and markets, the company’s current focus is on image analysis in Life Sciences and Healthcare. Definiens is currently in the process of establishing a scalable and profitable global business in this segment, and will expand into other areas in the future.
In the long term, Definiens aims to provide solutions for every possible situation where customers wish to gain high-quality information and intelligence from digital data.
Definiens is a DIN EN ISO 9001:2008 and EN ISO 13485:2007 certified company. Definiens’ process workflow – from design and development to production, sales, installation, and customer service – is fully compliant with the regulations defined by the international and European standardization authorities. The certification audit was conducted by the Landesgewerbeanstalt Bayern (notified body), a TÜVRheinland® company.
Join our online community to exchance thoughts with Definiens users or to provide suggestions. Visit our Digital Pathology Insights blog or watch recent webinars on our Definiens TV channel.
Definiens is the leading provider of image analysis and data mining solutions for life sciences, tissue diagnostics and clinical digital pathology. Definiens software provides detailed cell-by-cell readouts from target structures on whole tissue slides, and allows the correlation of this information with data derived from other sources, generating new knowledge and supporting better decisions in research, diagnostics and therapy.
